FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Colorectal Cancer
Related studies linked through entity extraction aliases.
Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum
- Status
- TERMINATED
- Phase
- PHASE3
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of ABT-751 in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum
- Status
- WITHDRAWN
- Phase
- PHASE2
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3